New Data from Universal DX Demonstrates Effective Detection of Early-stage Colorectal Cancer Using Combination of Methylation, Fragmentation and Machine Learning
/
DateJan 20 2023
Company to present results from the international cohort study at ASCO Gastrointestinal Cancers Symposium CAMBRIDGE, Mass.–(BUSINESS WIRE)–Universal Diagnostics (Universal DX), a bioinformatics and multi-omics company... Read More →


















